Global Gastrointestinal Bleeding Treatment Market Is Expected To Reach Around USD 827 Million By 2025

Zion Market Research has published a new report titled “Gastrointestinal Bleeding Treatment Market By Product (Endoscopic Hemostatic Devices, Thermal Devices, Mechanical Device, Closure Devices, and Others), By GI Tract Division (Upper and Lower), and By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global gastrointestinal bleeding treatment market was USD 608 million in 2018 and is expected to generate around USD 827 million by 2025, at a CAGR of 4.5% between 2019 and 2025.

Gastrointestinal (GI) bleeding is the bleeding of digestive tracts and is an extremely serious symptom that occurs within the digestive organs like esophagus, stomach, small intestine including the duodenum, rectum, etc. There are two types of GI bleeding, upper and lower. Gastrointestinal bleeding is one of the common conditions in the emergency department along with abdominal pain. Gastrointestinal bleeding has a death rate of 2.1% as per the stats provided by the U.S. National Library of Medicine. Comparatively, lower gastrointestinal bleeding has less than 5% death rate, but it is common among older people with comorbidity and ischemia. The main reason behind GI bleeding is induced mucosal damage, esophagitis, and ulcers. The growing aging population base is the major driver that is propelling this market. According to the World Health Organization, by 2050, a total 2 billion of world’s population will be aged 60 years and above; in 2015, 900 million of the world’s total population aged 60 years and above. The gastrointestinal bleeding treatment market is also growing due to the rising endoscopic hemostasis demand.

Browse the full “Gastrointestinal Bleeding Treatment Market By Product (Endoscopic Hemostatic Devices, Thermal Devices, Mechanical Device, Closure Devices, and Others), By GI Tract Division (Upper and Lower), and By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/gastrointestinal-bleeding-treatment-market

The market for gastrointestinal bleeding treatment is fragmented based on the product, GI tract division, and end-user. By product, the gastrointestinal bleeding treatment market includes thermal devices, endoscopic hemostatic devices, mechanical device, closure devices, and others. Thermal devices hold a major share of the market since these devices are used in hospitals for activating platelet thickening and producing tamponade for the underlying vessel. 

On the basis of GI tract division, the market includes lower and upper. Upper GI tract accounted for major share in the gastrointestinal bleeding treatment market in 2018 and is likely to register the highest CAGR in the future. The upper GI tract bleeding is among the most common causes of emergencies reported and also accounts for more than 250,000 annual hospitalizations in the U.K. and 240,000 in the U.S.

By end-user, the market for gastrointestinal bleeding treatment comprises hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment accounted for major market share in 2018, due to the advanced technologies for treatment and reimbursement plans provided by hospitals for endoscopic treatment.

North America and Europe are anticipated to account for major shares in the gastrointestinal bleeding treatment market globally in the years ahead. The Asia Pacific gastrointestinal bleeding treatment market is expected to register a high rate of growth in the future. There has been a sharp rise in the occurrences of various cardiovascular diseases along with the growing aging population that is accelerating the gastrointestinal bleeding treatment market growth in this region.

Some key players operating in the gastrointestinal bleeding treatment market are Erbe Elektromedizin, CONMED Corporation, Ovesco Endoscopy, U.S. Medical Innovations, and Boston Scientific Corporation.

This report segments the global gastrointestinal bleeding treatment market into:

Global Gastrointestinal Bleeding Treatment Market: Product Analysis

• Endoscopic Hemostatic Devices
• Thermal Devices
• Mechanical Devices
• Closure Devices
• Others

Global Gastrointestinal Bleeding Treatment Market: GI Tract Division Analysis

• Upper GI Tract
• Lower GI Tract

Global Gastrointestinal Bleeding Treatment Market: End-User Analysis

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Global Gastrointestinal Bleeding Treatment Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com